Suppr超能文献

人群中有害变异的流行率。

Population Prevalence of Deleterious Variants.

机构信息

Veracity Neuroscience LLC, Memphis, Tennessee, US.

University of Memphis, Memphis, Tennessee, US.

出版信息

Tremor Other Hyperkinet Mov (N Y). 2020 Nov 4;10:50. doi: 10.5334/tohm.567.

Abstract

BACKGROUND

Myoclonus-Dystonia (M-D) is a pleiotropic neuropsychiatric disorder of variable penetrance. Pathogenic variants in , a maternally imprinted gene, are the most frequent known genetic cause of M-D. The population prevalence of -linked M-D is unknown, the pathogenicity of variants identified in patients with M-D may be indeterminant, and variants predicted to be deleterious by analysis may appear in patients undergoing whole-exome or whole-genome sequencing for seemingly unrelated disorders. The Genome Aggregation Database (gnomAD) v2 provides variant data on 125,748 exomes and 15,708 genomes from unrelated individuals sequenced as part of various disease-specific and population genetic studies.

METHODS

variants included in the gnomAD v2 dataset were analyzed with Combined Annotation Dependent Depletion (CADD), and database for nonsynonymous single nucleotide polymorphisms' functional predictions (dbNSFP). We determined the frequency of annotated variants, ranked by scores of deleteriousness, within the gnomAD v2 dataset. Deleteriousness scores were compared to a subset of published disease associated pathogenic variants.

RESULTS

Within gnomAD v2, there were 56, 408, and 1250 alleles harboring variants with CADD scores greater than 30, 25, and 20, respectively. We estimate that approximately 1/348 individuals in the United States population harbors an variant with a CADD score ≥ 25.

DISCUSSION

M-D may be underdiagnosed due to pleiotropy, mild phenotypes, variable penetrance, and impaired access to genetic testing. Due to the high population prevalence of deleterious variants, caution should be used when asserting pathogenicity without co-segregation analyses and expert neurological examination of phenotypes within pedigrees.

HIGHLIGHTS

analyses of a large population database of genetic variants revealed that over 0.2% of individuals in the United States harbor a highly deleterious variant. This finding suggests that M-D and minor phenotypic variants such as mild isolated myoclonus may be underdiagnosed.

摘要

背景

肌阵挛 - 肌张力障碍(M-D)是一种具有可变外显率的多效性神经精神疾病。在母系印迹基因 中,致病性变异是 M-D 最常见的已知遗传原因。 - 连锁 M-D 的人群患病率未知,在 M-D 患者中鉴定出的致病性 变异可能不确定,并且通过 分析预测为有害的 变异可能出现在因看似无关的疾病而接受外显子组或全基因组测序的患者中。基因组聚集数据库(gnomAD)v2 提供了来自 125748 个外显子组和 15708 个基因组的变异数据,这些个体是作为各种疾病特异性和群体遗传学研究的一部分进行测序的无关个体。

方法

使用综合注释依赖耗竭(CADD)和非同义单核苷酸多态性功能预测数据库(dbNSFP)分析 gnomAD v2 数据集内的变异。我们确定了 gnomAD v2 数据集内按有害性评分排序的注释 变异的频率。将有害性评分与一组已发表的与疾病相关的致病性 变异进行比较。

结果

在 gnomAD v2 中,分别有 56、408 和 1250 个等位基因携带 CADD 评分大于 30、25 和 20 的 变异。我们估计,在美国人群中,大约有 1/348 的个体携带 CADD 评分≥25 的 变异。

讨论

由于多效性、轻度表型、可变外显率和获得遗传检测的机会有限,M-D 可能被误诊。由于有害的 变异的高人群患病率,在没有共分离分析和对家系内表型进行专家神经学检查的情况下,断言致病性时应谨慎。

重点

对大型遗传变异人群数据库的分析表明,美国有超过 0.2%的个体携带高度有害的 变异。这一发现表明,M-D 和轻度孤立性肌阵挛等轻微表型变异可能被误诊。

相似文献

1
Population Prevalence of Deleterious Variants.
Tremor Other Hyperkinet Mov (N Y). 2020 Nov 4;10:50. doi: 10.5334/tohm.567.
2
[Clinical and genetic analysis of childhood-onset myoclonus dystonia syndrome caused by SGCE variants].
Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):123-128. doi: 10.3760/cma.j.issn.0578-1310.2020.02.011.
3
Hereditary Myoclonus Dystonia: A Novel Variant and Phenotype Including Intellectual Disability.
Tremor Other Hyperkinet Mov (N Y). 2018 Mar 28;8:547. doi: 10.7916/D8J11FRZ. eCollection 2018.
4
Delayed Diagnoses of Myoclonus-Dystonia.
Tremor Other Hyperkinet Mov (N Y). 2020 Jul 28;10:23. doi: 10.5334/tohm.334.
5
Epsilon sarcoglycan mutations and phenotype in French patients with myoclonic syndromes.
J Med Genet. 2006 May;43(5):394-400. doi: 10.1136/jmg.2005.036780. Epub 2005 Oct 14.
6
SGCE and myoclonus dystonia: motor characteristics, diagnostic criteria and clinical predictors of genotype.
J Neurol. 2014 Dec;261(12):2296-304. doi: 10.1007/s00415-014-7488-3. Epub 2014 Sep 11.
7
SGCE mutations cause psychiatric disorders: clinical and genetic characterization.
Brain. 2013 Jan;136(Pt 1):294-303. doi: 10.1093/brain/aws308.
8
Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome.
Neurosci Lett. 2019 Jun 11;703:1-4. doi: 10.1016/j.neulet.2019.03.003. Epub 2019 Mar 5.

引用本文的文献

1
Natural history of SGCE-associated myoclonus dystonia in children and adolescents.
Dev Med Child Neurol. 2025 Jun;67(6):740-749. doi: 10.1111/dmcn.16214. Epub 2024 Dec 16.
2
The novel CFTR haplotype E583G/F508del in CFTR-related disorder.
Mol Biol Rep. 2024 Jul 25;51(1):849. doi: 10.1007/s11033-024-09732-x.
3
Introducing a new index for selecting genetic polymorphisms for association studies.
EXCLI J. 2022 Jun 10;21:814-817. doi: 10.17179/excli2022-5004. eCollection 2022.
5
Detection of a new deleterious gene variant in Moroccan family with inherited myoclonus-dystonia.
Clin Case Rep. 2022 Mar 17;10(3):e05568. doi: 10.1002/ccr3.5568. eCollection 2022 Mar.
6
A mixed-ethnicity myoclonus-dystonia patient with a novel SGCE nonsense mutation: a case report.
BMC Neurol. 2022 Jan 5;22(1):11. doi: 10.1186/s12883-021-02530-z.

本文引用的文献

1
Delayed Diagnoses of Myoclonus-Dystonia.
Tremor Other Hyperkinet Mov (N Y). 2020 Jul 28;10:23. doi: 10.5334/tohm.334.
2
Clinical utility of multigene analysis in over 25,000 patients with neuromuscular disorders.
Neurol Genet. 2020 Mar 9;6(2):e412. doi: 10.1212/NXG.0000000000000412. eCollection 2020 Apr.
3
Myoclonus-dystonia: Distinctive motor and non-motor phenotype from other dystonia syndromes.
Parkinsonism Relat Disord. 2019 Dec;69:85-90. doi: 10.1016/j.parkreldis.2019.10.015. Epub 2019 Oct 22.
4
Epidemiology of DYT1 dystonia: Estimating prevalence via genetic ascertainment.
Neurol Genet. 2019 Sep 13;5(5):e358. doi: 10.1212/NXG.0000000000000358. eCollection 2019 Oct.
5
Screening for SGCE mutations in Moroccan sporadic patients with Myoclonus-Dystonia syndrome.
Neurosci Lett. 2019 Jun 11;703:1-4. doi: 10.1016/j.neulet.2019.03.003. Epub 2019 Mar 5.
6
CADD: predicting the deleteriousness of variants throughout the human genome.
Nucleic Acids Res. 2019 Jan 8;47(D1):D886-D894. doi: 10.1093/nar/gky1016.
7
Predicting the clinical impact of human mutation with deep neural networks.
Nat Genet. 2018 Aug;50(8):1161-1170. doi: 10.1038/s41588-018-0167-z. Epub 2018 Jul 23.
8
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.
Am J Hum Genet. 2016 Oct 6;99(4):877-885. doi: 10.1016/j.ajhg.2016.08.016. Epub 2016 Sep 22.
9
Myoclonus-dystonia: An under-recognized entity - Report of 5 cases.
Neurol India. 2016 Sep-Oct;64(5):980-3. doi: 10.4103/0028-3886.190255.
10
Psychiatric disorders, myoclonus dystonia and SGCE: an international study.
Ann Clin Transl Neurol. 2015 Nov 20;3(1):4-11. doi: 10.1002/acn3.263. eCollection 2016 Jan.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验